AI assistant
Sending…
GILEAD SCIENCES, INC. — Director's Dealing 2013
May 14, 2013
29828_dirs_2013-05-14_2c6a794c-966e-4d90-847d-834630af15f1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2013-05-10
Reporting Person: HILLS CARLA A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-10 | Common Stock | M | 5852 | — | Acquired | 33052 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-10 | Restricted Stock Units | $ | M | 5852 | Disposed | Common Stock (5852) | Direct |
Footnotes
F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2: 100% of the restricted stock units vested on May 10, 2013, at the end of the first year of service.
More from GILEAD SCIENCES, INC.
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 14
Capital/Financing Update
2026
May 14
Regulatory Filings
2026
May 8
Share Issue/Capital Change
2026
May 7
Interim / Quarterly Report
2026
May 7
Report Publication Announcement
2026
May 7
Declaration of Voting Results & Voting Rights Announcements
2026
May 4
Major Shareholding Notification
2026
Apr 30